Healthcare provider profile · identity verified

Valarmathi Sundar, MD

Family Practice · HENDERSON, NC · NPI 1467420182

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	571	96
Eliquis	Apixaban	426	58
Furosemide	Furosemide	354	64
Pantoprazole Sodium	Pantoprazole Sodium	313	66
Potassium Chloride	Potassium Chloride	307	59
Tamsulosin Hcl	Tamsulosin Hcl	302	60
Metoprolol Tartrate	Metoprolol Tartrate	291	38
Omeprazole	Omeprazole	256	55
Gabapentin	Gabapentin	234	50
Levothyroxine Sodium	Levothyroxine Sodium	233	38
Amlodipine Besylate	Amlodipine Besylate	222	42
Hydralazine Hcl	Hydralazine Hcl	198	25
Prednisone	Prednisone	189	36
Carvedilol	Carvedilol	184	32
Mirtazapine	Mirtazapine	152	33
Metoprolol Succinate	Metoprolol Succinate	146	43
Clopidogrel	Clopidogrel Bisulfate	145	24
Sertraline Hcl	Sertraline Hcl	141	28
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	116	36
Colchicine	Colchicine	115	16
Rosuvastatin Calcium	Rosuvastatin Calcium	111	26
Midodrine Hcl	Midodrine Hcl	110	26
Spironolactone	Spironolactone	110	25
Torsemide	Torsemide	109	20
Lisinopril	Lisinopril	102	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	97	34
Doxycycline Hyclate	Doxycycline Hyclate	95	46
Allopurinol	Allopurinol	92	18
Latanoprost	Latanoprost	88	15
Methotrexate	Methotrexate Sodium	84	suppressed
Donepezil Hcl	Donepezil Hcl	78	13
Fluoxetine Hcl	Fluoxetine Hcl	77	suppressed
Humulin R	Insulin Regular, Human	74	20
Escitalopram Oxalate	Escitalopram Oxalate	71	16
Levetiracetam	Levetiracetam	70	11
Citalopram Hbr	Citalopram Hydrobromide	69	11
Finasteride	Finasteride	68	15
Nystatin	Nystatin	68	14
Trazodone Hcl	Trazodone Hcl	68	18
Glipizide	Glipizide	66	15
Oxycodone Hcl	Oxycodone Hcl	66	21
Novolin R	Insulin Regular, Human	60	13
Bethanechol Chloride	Bethanechol Chloride	58	14
Famotidine	Famotidine	54	13
Paroxetine Hcl	Paroxetine Hcl	54	suppressed
Symbicort	Budesonide/Formoterol Fumarate	54	16
Fluticasone Propionate	Fluticasone Propionate	53	16
Lorazepam	Lorazepam	53	14
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	49	suppressed
Xarelto	Rivaroxaban	48	suppressed
Breo Ellipta	Fluticasone/Vilanterol	47	suppressed
Ondansetron Hcl	Ondansetron Hcl	46	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	16
Methimazole	Methimazole	44	suppressed
Santyl	Collagenase Clostridium Hist.	44	13
Amiodarone Hcl	Amiodarone Hcl	42	12
Quetiapine Fumarate	Quetiapine Fumarate	42	suppressed
Risperidone	Risperidone	41	suppressed
Baclofen	Baclofen	38	suppressed
Buspirone Hcl	Buspirone Hcl	38	suppressed
Ketoconazole	Ketoconazole	38	18
Sucralfate	Sucralfate	38	12
Entresto	Sacubitril/Valsartan	37	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	36	19
Divalproex Sodium	Divalproex Sodium	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	19
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	33	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	16
Simvastatin	Simvastatin	32	suppressed
Mupirocin	Mupirocin	30	22
Cephalexin	Cephalexin	29	13
Lamotrigine	Lamotrigine	29	suppressed
Lansoprazole	Lansoprazole	29	suppressed
Tramadol Hcl	Tramadol Hcl	28	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Combigan	Brimonidine Tartrate/Timolol	25	suppressed
Dexamethasone	Dexamethasone	25	suppressed
Lactulose	Lactulose	25	13
Montelukast Sodium	Montelukast Sodium	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Bicalutamide	Bicalutamide	24	suppressed
Bumetanide	Bumetanide	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	12
Ezetimibe	Ezetimibe	23	suppressed
Fluconazole	Fluconazole	23	16
Myrbetriq	Mirabegron	23	suppressed
Losartan Potassium	Losartan Potassium	22	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Metformin Hcl	Metformin Hcl	21	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	suppressed
Linzess	Linaclotide	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	19	suppressed
Jardiance	Empagliflozin	19	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	18	suppressed
Enulose	Lactulose	18	suppressed
Insulin Lispro	Insulin Lispro	18	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	suppressed
Budesonide	Budesonide	17	suppressed
Ceftriaxone	Ceftriaxone Sodium	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	17	suppressed
Novolin R Flexpen	Insulin Regular, Human	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Breyna	Budesonide/Formoterol Fumarate	16	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Ciclopirox	Ciclopirox Olamine	14	12
Clonidine Hcl	Clonidine Hcl	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Ertapenem	Ertapenem Sodium	14	11
Incruse Ellipta	Umeclidinium Bromide	14	suppressed
Lidocaine Hcl	Lidocaine Hcl	14	12
Acyclovir	Acyclovir	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Propafenone Hcl	Propafenone Hcl	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Mitigare	Colchicine	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Primidone	Primidone	12	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	12	suppressed
Atenolol	Atenolol	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Lithium Carbonate	Lithium Carbonate	11	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	11	suppressed
Scopolamine	Scopolamine	11	suppressed
Tobramycin	Tobramycin	11	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	11	suppressed
Vancomycin Hcl	Vancomycin Hcl	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error